Standard Rheumatoid Arthritis Therapy as Good as Costlier Newcomer
Biologic drug Enbrel wasn't better for patients who didn't respond to methotrexate alone
Source: HealthDay
Related MedlinePlus Page: Rheumatoid Arthritis (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - June 11, 2013 Category: Consumer Health News Source Type: news
Traumatic Brain Injury Treatment Reduces Depression and Suicide Risk
Neurological Wellness Center physicians report the alleviation of depression is a predictable outcome of perispinal Enbrel treatment for traumatic brain injury. There is now substantial and...(PRWeb June 07, 2013)Read the full story at http://www.prweb.com/releases/2013/6/prweb10756643.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - June 7, 2013 Category: Pharmaceuticals Source Type: news
Newly Published Medical Research Confirms the Efficacy of Perispinally...
Observational Study by Neurological Wellness Center Physicians Confirms Significant Recoveries with Perispinal Etanercept Administered Years After the Injury.(PRWeb May 15, 2013)Read the full story at http://www.prweb.com/releases/2013/5/prweb10583458.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - May 15, 2013 Category: Pharmaceuticals Source Type: news
Lobby fears norms violation in Cipla's biosimilar drug
A lobby group of biotech drug companies in India has raised concerns about the approval of Cipla's first biosimilar drug Etanercept. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 14, 2013 Category: Pharmaceuticals Source Type: news
Alzheimer's Treatment Clinical Trial Receives Clearance
Neurological Wellness Center to launch a clinical trial of perispinally administered etanercept as an Alzheimer's disease treatment.(PRWeb May 01, 2013)Read the full story at http://www.prweb.com/releases/2013/5/prweb10603523.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - May 2, 2013 Category: Pharmaceuticals Source Type: news
Neurological Wellness Center Physicians Group Asks CBS to Air the...
The 14-minute segment that aired on 60 Minutes Australia features a man, Charlie Giales, with severe Alzheimer’s receiving a perispinal injection of the drug Enbrel. Within minutes of receiving this...(PRWeb April 10, 2013)Read the full story at http://www.prweb.com/releases/2013/4/prweb10525725.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - April 14, 2013 Category: Pharmaceuticals Source Type: news
Enbrel (etanercept) - all formulations - Revised SPC
Source: eMC (electronic Medicines Compendium)
Area: Other Library Updates > SPC Changes
Section 4.8 (undesirable effects) of the SPC has been updated to include Hepatitis B reactivation as an adverse reaction of unknown prevalence.
Hepatitis B is included in the list of serious infections that occurred in 6.3% of rheumatoid arthritis patients treated with Enbrel for up to 48 months.
Please see seperate SPC links for full prescribing information. (Source: NeLM - SPC Changes)
Source: NeLM - SPC Changes - February 12, 2013 Category: Drugs & Pharmacology Source Type: news
SMC accepts etanercept (Enbrel®) for restricted use in the treatment of arthritis in children and adolescents
Source: Scottish Medicines Consortium (SMC)
Area: Evidence > Drug Specific Reviews
The Scottish Medicines Consortium (SMC) has accepted etanercept (Enbrel®) for restricted use within NHS Scotland for the treatment of the following:
polyarthritis (rheumatoid factor positive or negative) and extended oligoarthritis in children and adolescents from the age of 2 years who have had an inadequate response to, or who have proved intolerant of, methotrexate;
psoriatic arthritis in adolescents from the age of 12 years who have had an inadequate response to, or who have proved intolerant of, methotrexate;
en...
Source: NeLM - Drug Specific Reviews - February 11, 2013 Category: Drugs & Pharmacology Source Type: news
Etanercept no better than prednisone for COPD exacerbations
Results from a randomized, double-blind, controlled trial suggest that the tumor necrosis factor α antagonist etanercept is no more effective than standard therapy with prednisone for the treatment of acute exacerbations in patients with chronic obstructive pulmonary disease. (Source: MedWire News - Respiratory)
Source: MedWire News - Respiratory - February 8, 2013 Category: Respiratory Medicine Source Type: news
Amgen biosimilar push takes aim at blockbusters
NEW YORK (Reuters) - Amgen Inc said it expects generic versions of biotech drugs, known as biosimilars, to be a multibillion-dollar opportunity for the company and has targeted some of the industry's biggest sellers, including the main rivals for its own blockbuster rheumatoid arthritis drug Enbrel. (Source: Reuters: Health)
Source: Reuters: Health - February 7, 2013 Category: Consumer Health News Tags: healthNews Source Type: news
Amgen Outlines Long-Term Strategy
Amgen Emphasizes Pipeline, International Expansion and Biosimilars as Growth Drivers
Pivotal Data from Eight Late-Stage Programs Anticipated Between 2013 and 2016
NEW YORK, Feb. 7, 2013 -- (Healthcare Sales & Marketing Network) -- Amgen (AMGN) today... BiopharmaceuticalsAmgen, Enbrel, Prolia, XGEVA, Sensipar, Vectibix, Romosozumab (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 7, 2013 Category: Pharmaceuticals Source Type: news
Physicians Group Calls on the FDA to Repurpose Enbrel for the...
A newly released study involving 629 patients has inspired Neurological Wellness Center physicians to lament that the lives of millions would be meaningfully ameliorated if perispinal Enbrel...(PRWeb February 06, 2013)Read the full story at http://www.prweb.com/releases/2013/2/prweb10319406.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - February 7, 2013 Category: Pharmaceuticals Source Type: news
TNF Alpha Antagonists for Acute Exacerbations of COPDTNF Alpha Antagonists for Acute Exacerbations of COPD
Does etanercept provide more effective anti-inflammatory treatment than prednisone -- for acute COPD exacerbations? Thorax (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 7, 2013 Category: Consumer Health News Tags: Pulmonary Medicine Journal Article Source Type: news
RCT: Maintenance, reduction, or withdrawal of etanercept after treatment with etanercept and methotrexate in patients with moderate rheumatoid arthritis (PRESERVE)
Source: Lancet
Area: News
Although moderately active rheumatoid arthritis is common, treatment effects in moderate disease have not been well studied. In addition, the optimum use of biologics requires further investigation, including the use of induction, maintenance, and withdrawal treatment strategies.
The PRESERVE trial in The Lancet compared the efficacy of maintenance, reduction, or withdrawal of etanercept in patients aged between 18 and 70 years with moderately active disease (DAS28 >3.2 and ?5.1) despite treatment with methotrexate (15 to 25 mg every week for at least 8 weeks). In a 36 week open-l...
Source: NeLM - News - January 17, 2013 Category: Drugs & Pharmacology Source Type: news
Neurological Wellness Center Posts 700% Sales Increase in 2012; Enters...
Neurological Wellness Center utilizes the drug Enbrel in an off-label manner to induce dramatic and sustained recovery of physical and cognitive function in individuals affected by Alzheimer’s...(PRWeb January 09, 2013)Read the full story at http://www.prweb.com/releases/2013/1/prweb10268926.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - January 10, 2013 Category: Pharmaceuticals Source Type: news
